Platelet Count Measured Prior to Cancer Development Is a Risk Factor for Future Symptomatic Venous Thromboembolism: The Tromsø Study

BACKGROUND: Elevated platelet count is associated with risk of venous thromboembolism in cancer patients initiating chemotherapy. It is not known whether this risk by platelet count is causal or merely reflects the malignant disease. We investigated whether pre-cancer platelet count alone or togethe...

Descripción completa

Detalles Bibliográficos
Autores principales: Jensvoll, Hilde, Blix, Kristine, Brækkan, Sigrid K., Hansen, John-Bjarne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3958406/
https://www.ncbi.nlm.nih.gov/pubmed/24642868
http://dx.doi.org/10.1371/journal.pone.0092011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3958406/
https://www.ncbi.nlm.nih.gov/pubmed/24642868
http://dx.doi.org/10.1371/journal.pone.0092011

Ejemplares similares